Consequently, the binding of transcription factors (T-cell factor 1/lymphoid enhancer factor 1) to promoters of CD274 and O6-methylguanine-DNA methyltransferase (MGMT) was impeded, thereby enhancing GBM cell susceptibility to TMZ. Here, CD274 is linked to glioblastoma.